Europe Medical Second Opinion Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.

Europe Medical Second Opinion Market Outlook

The medical second opinion is intended to provide valuable information about a patient's current treatment options. It plays a major role in resolving the confusion created by the recommendation of several treatment alternatives for a single case. Besides, opinion is also sought to gain additional information, which can be beneficial to improve treatment outcomes. The medical second opinion can validate the diagnosis; thus, it is a major factor in increasing the accuracy of the treatment. The increasing emphasis on improving treatment outcomes leads to the growth of the medical second opinion market. There is a high possibility of the occurrence of adverse effects of many treatment procedures, which might as well lead to mortality. Consequently, in crucial cases, it is essential to revise the current treatment options and get advice from a reliable healthcare professional to avoid potential ill-effects. Per the World Health Organization (WHO), unsafe medical care causes more than 3 million deaths each year globally. According to the World Health Organization data, approximately 9.7 million patients across the globe lost their lives due to cancer in 2022. Furthermore, the increasing exposure to risk factors such as tobacco consumption, alcohol consumption, altering food habits, and obesity is also causing a rise in the prevalence of cancer. Thus, the increasing prevalence of cancer and other chronic diseases, such as cancer looking for a second opinion for better patients comes, is one of the prominent factors driving the medical second opinion market growth.

Europe Medical Second Opinion Market Country Insights

Based on country, the Europe medical second opinion market comprises Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.

The market for medical second opinion in Germany is anticipated to grow significantly during the forecast period owing to the increasing prevalence of chronic diseases. In Germany, cancer is one of the leading causes of morbidity and mortality, and it is rising every year, with lung cancer, prostate cancer, bladder cancer, colorectum cancer, and skin cancer being reported the most. According to the World Health Organization (WHO), 628,519 new cancer cases were diagnosed and 252,065 deaths were recorded in 2020 in Germany. The increasing number of cancer cases in Germany accelerates the demand for better diagnostics and therapeutics; therefore, cancer patients have a higher emphasis on getting a medical second opinion.
Furthermore, the Federal Ministry of Health and Social Security and the Federal Ministry of Justice have jointly published a "Charter of Patients' Rights in Germany." According to the Charter of Patients' Rights in Germany, patients have a fundamental right to obtain a second medical opinion. This means that doctors must cooperate if a patient requests to be assessed by a second doctor. IMC Intermed-Consult is the only German healthcare service provider offering a premium-class full-service concept for international patients. It is managed and led by an experienced team of medical doctors who can provide patients with a second opinion regarding their condition. Additionally, Germany Health provides medical second opinions through highly qualified and independent medical experts who evaluate patients' initial diagnoses. It offers medical second opinion services for cancer, orthopedic surgery, cardiovascular disease, brain tumors, and spine surgery.
The presence of local market players in Germany and their developments are also likely to favor the medical second opinion market growth in Germany. For instance, the Clinic of Friedrichshafen has launched a new medical tele-counseling service, allowing international patients to gain more information and beneficial alternatives for managing their medical condition cost-effectively.

Europe Medical Second Opinion Market Report Highlights

Europe Medical Second Opinion Market Company Profiles

Some of the key players operating in the market include Second Opinion International; Elite Medical Services; The Cigna Group; Helsana; WorldCare; Vidal Health Insurance TPA Pvt Ltd; 2nd.MD; Axa SA; Teladoc Health Inc; Included Health, Inc.; and Royal Doctors among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Medical Second Opinion Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Europe Medical Second Opinion Market Country and Regional Insights